JGJose Garcia-Flores

Jose Garcia-Flores

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jose Garcia-Flores has a total of 55 co-authors. Here are the top co-authors by number of shared publications:

  • Marina Cañamares

    Obstetrics and Gynecology, Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcon Madrid Spain

    6 shared publications
  • Mireia Cruceyra

    High-Risk Pregnancy Unit, Obstetrics & Gynecology Department, Hospital Universitario Quiron Madrid, Pozuelo de Alarcon (Madrid), Spain

    6 shared publications
  • Ainhoa Garicano

    High-Risk Pregnancy Unit, Obstetrics & Gynecology Department, Hospital Universitario Quiron Madrid, Pozuelo de Alarcon (Madrid), Spain

    5 shared publications
  • Ines Tamarit

    High-Risk Pregnancy Unit, Obstetrics & Gynecology Department, Hospital Universitario Quiron Madrid, Pozuelo de Alarcon (Madrid), Spain

    5 shared publications
  • Mercedes Espada

    Department of Obstetrics and Gynaecology, Nepean Hospital, Kingswood, NSW 2747, Australia

    5 shared publications
  • Mercedes Espada

    High-Risk Pregnancy Unit, Obstetrics & Gynecology Department, Hospital Universitario Quiron Madrid, Pozuelo de Alarcon (Madrid), Spain

    4 shared publications

Latest Publications

  • Open Access

    Cardiotoxicidad como causa de insuficiencia cardíaca con fracción de eyección reducida

    by Eduardo Sánchez Martínez, Claudia Moreno Navarro, Teresa Martinez-Carbonell Baeza, Carmen González Tudela, Christian Ruzafa Martinez, Mariano Gambin Arronoz, Jose Garcia Flores, Gonzalo Rocha De Lossada, Jose Javier Tercero Fajardo, Beatriz Castillo Guardiola

  • Sonographic Evaluation of Fetal Adrenal Gland in Gestational Diabetes

    by Jose Garcia-Flores, Mireia Cruceyra, Marina Cañamares, Ainhoa Garicano, Mercedes Espada, Olga Nieto, Ines Tamarit, Ricardo Sainz de la Cuesta

    To relate measurements and volume of the fetal adrenal gland in third trimester ultrasound in diabetic pregnancies (1) to birth weight; (2) to other sonographic markers of diabetic fetopathy (expected fetal weight, sectional area, and fractional volume in fetal limbs); and (3) to maternal biochemical markers of diabetes (HbA1c, leptin). Fetal adrenal gland measurements were obtained between 32 and 34 weeks. The gland length, width, depth, and volume (by Virtual Organ Computer-Aided Analysis [VOCAL]) were measured for total gland and fetal zone. Fetal total and fat sectional area and fractional volume were obtained in arm and thigh. A maternal blood sample was obtained. Univariate and multivariate models were used to assess the associations. Thirty-nine diabetic pregnancies were included. Birth weight related significantly to total and fetal zone adrenal depth, and total adrenal volume in third trimester. Total adrenal length and corrected adrenal gland volume also showed a significant correlation to birth weight percentile in univariate and multivariate models. Total adrenal volume associated significantly to total and fat areas and volumes in fetal limbs. Both maternal leptin and HbA1c levels found a significant positive relation to fetal total adrenal volume and corrected adrenal gland volume. Total adrenal gland volume showed a significant association to maternal HbA1c level in multivariate model. An enlargement of the fetal adrenal gland may be observed in gestational diabetes, not only related to birth weight, but also to distinctive features of diabetic pregnancies, such as fat tissue fetal deposits or maternal biochemical markers.


  • Candida chorioamnionitis: Report of two cases and review of literature

    by Jose Garcia-Flores, Mireia Cruceyra, Marina Cañamares, Ainhoa Garicano, Olga Nieto, Ines Tamarit

    (2016). Candida chorioamnionitis: Report of two cases and review of literature. Journal of Obstetrics and Gynaecology: Vol. 36, No. 7, pp. 843-844.


  • Predictive value of fetal hepatic biometry for birth weight and cord blood markers in gestational diabetes

    by J Garcia-Flores, M Cruceyra, M Cañamares, A Garicano, O Nieto, I Tamarit

    JPER is a multi-disciplinary journal that promotes the health of the preterm infant.


    • 1 February 2016
      • Vol. 68  (1) , 92-96

    Immediate postpartum evaluation of clinical markers for depression symptoms by means of the Edinburgh Postnatal Depression Scale

    by Jose R. Garcia-Flores, Santiago Peregalli, Silvia Garrido, Susana Garcia-Diaz, Mercedes Espada, Ricardo Sainz De La Cuesta


  • Weight-related and analytical maternal factors in gestational diabetes to predict birth weight and cord markers of diabetic fetopathy

    by Jose Garcia-Flores, Mireia Cruceyra, Marina Cañamares, Ainhoa Garicano, Olga Nieto, Mercedes Espada, Ana Lopez, Ines Tamarit, Ricardo Sainz De La Cuesta

    Objective: The objective was to determine the value of clinical and analytical maternal factors to predict birth weight and umbilical cord biochemical markers of diabetic fetopathy. Methods: Prospective evaluation of gestational diabetes pregnancies (n = 50). Maternal weight-related clinical and analytical factors were collected during pregnancy. After birth, an umbilical cord sample was taken. Results: Univariate linear regression analysis showed relationship between maternal weight, glycated hemoglobin (HbA1c) and insulin-like growth factor 1 (IGF1) with birth weight percentile. A significant association was found between maternal weight and cord insulin and C-peptide. Maternal HbA1c, leptin and insulin during pregnancy showed a positive linear association to cord leptin, insulin and C-peptide. In multivariate analysis models, final maternal BMI showed an independent positive association with cord C-peptide. Conclusions: Maternal weight-related and analytical parameters show diagnostic value to birth weight and cord markers.


  • Fetal limb soft tissue assessment for prediction of birth weight and umbilical cord blood analytes in gestational diabetes

    by Jose Garcia‐Flores, Mireia Cruceyra, Marina Cañamares, Ainhoa Garicano, Olga Nieto, Ana Lopez, Izaskun Dorronsoro, Ines Tamarit, Ricardo Sainz De La Cuesta

    Objective: To evaluate the value of third trimester ultrasound (estimated fetal weight, cheek‐to‐cheek diameter, sectional Wharton's jelly area, sectional areas and fractional volumes in extremities) to predict birth weight and cord biochemical markers at birth (leptin, insulin, c‐peptide, IGF1, erythropoietin and ferritin) in diabetic pregnancies.Method: Prospective study in 49 patients with gestational diabetes. An ultrasound was performed between 32 and 34 weeks. Clinical data were collected, and a blood sample was obtained from cord after birth. ROC curve models were evaluated for 75th and 90th birth weight percentile. Univariate and multivariate models were used to assess the association between ultrasound and neonatal outcomes.Results: Sectional areas and fractional volumes showed significant differences and highest AUC values for predicting birth weight. A significant association was found for extremities measurements with total birth weight and its percentile. The only marker which showed a significant association to estimated fetal weight was erythropoietin. Sectional areas and fractional volumes related to cord leptin, erythropoietin, insulin and c‐peptide.Conclusion: Sectional areas and fractional volumes improve the predictive value of estimated fetal weight in diabetic pregnancies. They also show a predictive association to biochemical changes in cord (leptin, insulin and erythropoietin) related to increased adiposity and risk of fetal hypoxia. © 2015 John Wiley & Sons, Ltd.


  • Clinical Value of Maternal Bile Acid Quantification in Intrahepatic Cholestasis of Pregnancy as an Adverse Perinatal Outcome Predictor

    by Jose Garcia-Flores, Marina Cañamares, Mireia Cruceyra, Ainhoa Garicano, Mercedes Espada, Ana Lopez, Ines Tamarit

    Aims: To evaluate the correlation between perinatal outcome and bile acid levels in intrahepatic cholestasis of pregnancy (ICP), and to evaluate variations in the mean bile acid level when stratifying by maternal and perinatal factors. A comparison between mild and severe ICP was made. Methods: A prospective observational study was performed in pregnant patients who underwent blood tests for bile acids due to persistent pruritus. Based on bile acid levels, maternal and neonatal data were obtained and were compared between patients presenting with ICP and gestational pruritus (normal bile acid level). Results: A total of 145 patients were included, 47 of whom were diagnosed as ICP (52 newborns) and 98 as gestational pruritus (102 newborns). The ICP group had a higher rate of NICU admission (14/42 vs. 6/98, p < 0.001) and global neonatal morbidity (13/42 vs. 9/98, p = 0.002), but these differences were no longer seen after adjusting for gestational age, singleton pregnancies and induction of labour. Patients presenting with severe ICP (maximum bile acids levels above 40 µmol/l) showed a higher rate of meconium-stained amniotic fluid (0/28 vs. 4/14, p = 0.009), NICU admission (9/34 vs. 11/17, p = 0.01) and neonatal global morbidity (5/32 vs. 8/17, p = 0.02). Conclusions: ICP patients have higher rates of adverse neonatal outcomes when compared to those with gestational pruritus. Some of this neonatal morbidity may be secondary to late spontaneous preterm deliveries, multiple gestation and a policy of elective induction of labour after 37 weeks of gestation. A comparison of outcomes among patients with mild and severe ICP shows that the severely affected group has higher rates of meconium-stained amniotic fluid and neonatal morbidity.


  • Fetal magnetic resonance imaging and neurosonography in congenital neurological anomalies: supplementary diagnostic and postnatal prognostic value

    by Jose Garcia-Flores, Manuel Recio, Monserrat Uriel, Marina Cañamares, Mireia Cruceyra, Inés Tamarit, Javier Carrascoso, Mercedes Espada, Ricardo Sáinz de la Cuesta

    Objective: To compare the diagnostic conclusions between fetal neurosonography and MRI in the cases of congenital neurological abnormalities, and with postnatal clinical and imaging evaluation, when available. Methods: A retrospective study of 28 patients who underwent a fetal MRI study for suspected congenital neurological anomalies. The diagnoses obtained by neurosonography and MRI were collected and compared. Both of them were compared with the final diagnosis when available by necropsy or postnatal evaluation. Postnatal imaging tests were performed only when clinically indicated. Results: The indications for the fetal MRI examination were: fetal ventriculomegaly, posterior fossa anomalies, suspected midline defects, small-for-gestational-age cephalic biometry and confirmed congenital CMV infection. There was a good degree of agreement beyond chance between both techniques (kappa test = 0.76). Conclusions: Both imaging modalities give a high-diagnostic performance with a good degree of agreement between them, when made by specialized staff. Fetal MRI is a valuable complementary tool to detailed neurosonography which allows an evaluation of the normal brain maturation from the second trimester. It also offers a higher diagnostic performance for some congenital abnormalities such as cortical development or acquired lesions.


  • Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma

    by Mercedes Espada, Jose R. Garcia-Flores, Mar Jimenez, Elena Alvarez-Moreno, Mar De Haro, Lucia Gonzalez-Cortijo, Gines Hernandez-Cortes, Vicente Martinez-Vega, Ricardo Sainz De La Cuesta

    To analyse the diagnostic accuracy and to establish a predictive score based on diffusion-weighted magnetic resonance imaging (DWMRI) compared to exploratory laparotomy (EL) for predicting suboptimal cytoreductive surgery for different intra-abdominal sites of implants in patients with ovarian cancer. Thirty-four patients with advanced ovarian carcinoma were studied. Preoperative DWMRI of the abdomen and pelvis was performed. DWMRI findings were compared with EL. Ten anatomical sites were selected for inclusion in the score. Sensitivity, specificity, positive predictive value, negative predictive value and accuracy for suboptimal cytoreduction were calculated for both DWMRI and EL. Receiver operating characteristic (ROC) curve analysis was used to assess the ability to predict suboptimal cytoreduction. Using predictive score, ROC curves were generated with an area under the curve of 0.938 for DWMRI and 0.947 for EL (P < 0.0001). For DWMRI, a score ≥6 had the highest overall accuracy at 91.1 % and identified patients with unnecessary EL with a sensitivity of 75 %. For EL, a score ≥4 had the highest overall accuracy at 88.2 % and was able to identify patients with unnecessary EL with a sensitivity of 87.5 %. DWMRI is an emerging technique that may be useful to predict suboptimal cytoreduction in ovarian cancer. • DWMRI is increasingly used in ovarian cancer. • DWMRI is an accurate technique for depicting intra-abdominal sites of implants • DWMRI is useful for predicting optimal cytoreductive surgical outcome. • We report a high predictive value similar to exploratory laparotomy.